RCC has a five-year survival rate of above 70%, according to the National Cancer Institute. Renal cell carcinoma is one of the most rapidly growing solid tumor cancers. The clinical paradigm that governs both renal cell carcinoma comprehension and treatment has changed dramatically during the last few decades. Renal cell carcinoma is the eighth most prevalent cancer in adults, accounting for between 3% and 4% of all new cancer cases worldwide. Various renowned research institutes have calculated that renal cell carcinoma is the seventh most prevalent cancer in men and the ninth most common cancer in women.
